MedPath

LearningRx Cognitive Training for ADHD

Not Applicable
Completed
Conditions
Attention Deficit Hyperactivity Disorder (ADHD)
Registration Number
NCT02917109
Lead Sponsor
Gibson Institute of Cognitive Research
Brief Summary

The purpose of this investigation is to conduct a series of case studies on the impact of LearningRx cognitive training on cognitive skills, brain structure, and daily functioning for participants with ADHD.

Detailed Description

Using a multiple baseline design across cases with start point randomization, the proposed study will examine the outcomes from LearningRx one-on-one cognitive training across domains on standardized measures used to monitor treatment effectiveness for ADHD.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
3
Inclusion Criteria
  • Age 15-22 previously diagnosed with ADHD
  • High school students or college students with a prior diagnosis of ADHD living in the greater Colorado Springs area
Exclusion Criteria
  • No braces, metal implants, or claustrophobia that would contraindicate magnetic resonance imaging

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Primary Outcome Measures
NameTimeMethod
Evidence of overall cognitive function improvementwithin 14 days after completing the intervention

Confirmed by change in pretest to post-test scores on the Woodcock Johnson IV - Tests of Cognitive Abilities

Secondary Outcome Measures
NameTimeMethod
Evidence of change in brain structurewithin 30 days after completing the intervention

Confirmed by change in pretest to post-test neuroimaging using MRI

Evidence of reduction in ADHD symptomswithin 14 days after completing the intervention

As confirmed by pretest to post-test changes on the ADHD Rating Scale

Evidence of change in brain activitywithin 30 days after completing the intervention

As confirmed by pretest to post-test changes in electrical activity measured by qEEG

Evidence of improvement in visual or auditory attentionwith 14 days after completing the intervention

Confirmed by change in pretest to post-test scores on the Conners Continous Performance Test (CPT-3) and Auditory Attention Test (CATA)

Trial Locations

Locations (1)

Gibson Institute of Cognitive Research

🇺🇸

Colorado Springs, Colorado, United States

Gibson Institute of Cognitive Research
🇺🇸Colorado Springs, Colorado, United States

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.